Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 24.88%4.09B | 25.92%7.01B | 27.12%3.27B | 35.31%5.57B | 29.67%2.57B | 45.66%4.12B | 51.53%1.99B | 31.46%2.83B | 22.32%1.31B | -0.88%2.15B |
| Operating income | 24.88%4.09B | 25.92%7.01B | 27.12%3.27B | 35.31%5.57B | 29.67%2.57B | 45.66%4.12B | 51.53%1.99B | 31.46%2.83B | 22.32%1.31B | -0.88%2.15B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-6M | 150.00%1M | ---2M |
| Depreciation and amortization | -51.54%-1.77B | -37.47%-2.62B | -38.39%-1.17B | -44.60%-1.9B | -30.45%-844M | -64.91%-1.32B | -83.81%-647M | -32.12%-798M | -18.12%-352M | 0.49%-604M |
| Revaluation surplus | ---- | -4,100.00%-42M | -366.67%-40M | 95.65%-1M | 350.00%15M | 46.51%-23M | 89.29%-6M | ---43M | ---56M | ---- |
| -Changes in the fair value of financial assets | ---- | ---2M | ---- | ---- | ---- | 66.67%-1M | ---- | ---3M | ---- | ---- |
| -Changes in the fair value of other assets | ---- | -3,900.00%-40M | -366.67%-40M | 95.45%-1M | 350.00%15M | 45.00%-22M | 89.29%-6M | ---40M | ---56M | ---- |
| Impairment and provision | ---- | 101.22%2M | ---- | -556.00%-164M | ---- | 65.28%-25M | ---- | -2,300.00%-72M | ---3M | 99.89%-3M |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---163M | ---- | ---- | ---- | -133.33%-7M | ---- | 99.69%-3M |
| -Other impairment is provision | ---- | 300.00%2M | ---- | 96.00%-1M | ---- | 61.54%-25M | ---- | ---65M | ---3M | --0 |
| Special items of operating profit | -32.42%-723M | -48.84%-1.28B | -35.15%-546M | -39.71%-862M | -43.77%-404M | -319.73%-617M | -685.42%-281M | -4.26%-147M | 158.54%48M | 32.86%-141M |
| Operating profit | 3.69%1.55B | 16.19%3B | 13.22%1.49B | 23.01%2.58B | 27.27%1.32B | 21.19%2.1B | 10.47%1.03B | 25.87%1.73B | 36.64%936M | 193.92%1.38B |
| Financing income | -95.92%2M | 26.09%87M | -44.94%49M | 81.58%69M | 304.55%89M | -70.54%38M | -73.81%22M | 61.25%129M | 366.67%84M | 3.90%80M |
| Financing cost | 0.54%-1.1B | -19.13%-2.38B | -3.95%-1.11B | -31.90%-2B | -53.61%-1.06B | -36.40%-1.51B | -13.26%-692M | 0.00%-1.11B | -7.38%-611M | 10.41%-1.11B |
| Special items of earning before tax | ---- | --6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.83%-2M |
| Earning before tax | 3.23%448M | 9.17%714M | 26.90%434M | 4.98%654M | -6.04%342M | -17.04%623M | -11.00%364M | 118.31%751M | 209.85%409M | 109.10%344M |
| Tax | -9.15%-155M | 13.74%-157M | -49.47%-142M | -20.53%-182M | -21.79%-95M | -49.50%-151M | -62.50%-78M | -23.17%-101M | -23.08%-48M | -129.29%-82M |
| After-tax profit from continuing operations | 0.34%293M | 18.01%557M | 18.22%292M | 0.00%472M | -13.64%247M | -27.38%472M | -20.78%286M | 148.09%650M | 288.17%361M | 107.49%262M |
| Earning after tax | 0.34%293M | 18.01%557M | 18.22%292M | 0.00%472M | -13.64%247M | -27.38%472M | -20.78%286M | 148.09%650M | 288.17%361M | 107.50%262M |
| Minority profit | -53.67%120M | 9.53%471M | 85.00%259M | 111.82%430M | 33.33%140M | 136.05%203M | 1,150.00%105M | 309.52%86M | -225.00%-10M | 109.55%21M |
| Profit attributable to shareholders | 424.24%173M | 104.76%86M | -69.16%33M | -84.39%42M | -40.88%107M | -52.30%269M | -51.21%181M | 134.02%564M | 336.47%371M | 107.36%241M |
| Dividend | -1.53%193M | -1.51%196M | -1.51%196M | --199M | --199M | ---- | ---- | ---- | ---- | ---- |
| Basic earnings per share | 431.76%0.0787 | 114.36%0.0388 | 208.33%0.0148 | 50.83%0.0181 | -40.74%0.0048 | -52.19%0.012 | -50.91%0.0081 | 124.11%0.0251 | 302.44%0.0165 | 104.79%0.0112 |
| Diluted earnings per share | 431.76%0.0787 | 114.36%0.0388 | 208.33%0.0148 | 50.83%0.0181 | -40.74%0.0048 | -52.19%0.012 | -50.91%0.0081 | 124.11%0.0251 | 302.44%0.0165 | 104.79%0.0112 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.